Bristol-Myers Squibb shells out billions for Mirati: 5 big deal reports
Investing.com — Here is your Pro Recap of 5 head-turning deal dispatches you may have missed last week: deals at Bristol Myers Squibb/Mirati Therapeutics, Eli Lilly/Point Biopharma, Suncor Energy/TotalEnergies, deal talks at Exxon Mobil/Pioneer Natural Resources, and potential sale of EngageSmart.
InvestingPro subscribers got this news first. Never miss another market-moving headline.
Bristol Myers Squibb acquires Mirati Therapeutics in a deal worth up to $5.8 billion
Bristol-Myers Squibb (NYSE:BMY) said Sunday that it has agreed to buy out Mirati Therapeutics (NASDAQ:MRTX) for $58.00 per share in cash, for a total equity value of $4.8 billion.
Mirati shareholders will also be granted a non-tradeable Contingent Value Right (CVR) for each Mirati share held, with the potential to be valued at $12 per share in cash, presenting an extra $1B in potential value.
Earlier last week, Reuters reported that French pharmaceutical giant Sanofi (NASDAQ:SNY) is exploring a potential acquisition of Mirati Therapeutics, which led to a 45% share surge on Thursday.
ExxonMobil in talks to acquire Pioneer Natural Resources for $60B
Pioneer Natural Resources (NYSE:PXD) soared 10% Friday on reports of ongoing negotiations between Exxon Mobil (NYSE:XOM) and the shale driller.
According to sources cited by the Wall Street Journal, this potential blockbuster deal could be valued at around $60B and may be finalized in the coming days, marking one of the oil group's largest acquisitions in more than two decades.
Pioneer shares were recently up another 1.7% in premarket trading Monday. Exxon shares were climbing 2.5%.
Point Biopharma to be acquired by Eli Lilly for $1.4B
POINT Biopharma Global (NASDAQ:PNT) shares surged by more than 85% last Tuesday after Eli Lilly (NYSE:LLY) said it had agreed to buy the cancer biotech for around $1.4 billion. Under the terms of the deal, Lilly is offering $12.50 per Point Biopharma share held. Both Point and Lilly expect the deal to close by the end of the year.
Eli Lilly shares closed the week with more than a 5% gain.
Suncor buys TotalEnergies Canada
Suncor Energy (NYSE:SU) said it picked up TotalEnergies' (EPA:TTEF) Canada operations - TotalEnergies EP Canada Ltd - which holds a 31.23% working interest in the Fort Hills oil sands mining project, for C$1.468 billion.
Upon closing of the transaction, Suncor will own 100% of Fort Hills, which along with its 100% ownership of Firebag and MacKay River in-situ assets, enhances Suncor's access to long-life, physically-integrated bitumen supply, maximizing the utilization of its wholly-owned Base Plant upgraders post the end of the Base Mine life.
General Atlantic mulls sale of EngageSmart
General Atlantic LLC, a private equity firm, is reportedly considering the sale of EngageSmart (NYSE:ESMT), per Reuters. Investment banks Goldman Sachs Group and Evercore are working with EngageSmart on a sale process, which is in its early stages.
According to the report, no definitive deal has been confirmed, and General Atlantic, which holds a 54% stake in EngageSmart, may opt for a gradual sell-down of its stake on the stock market instead.
EngageSmart shares closed the week with more than a 15% gain.
***
Get a leg up on the market: Always be the first to know with InvestingPro.
Related Articles
Bristol-Myers Squibb shells out billions for Mirati: 5 big deal reports
Analysis-Why Elon Musk might lose his latest battle with the SEC over Twitter probe